Please refer to the attachment.
THEMISMED · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Themis Medicare has circulated the notice for its 55th AGM scheduled for Friday, 12th September 2025 at 10:00 a.m. at the registered office in Vapi, Gujarat, along with the Annual Report for FY 2024-25. Ordinary business items include adoption of financial statements, re-appointment of Dr. Adam Demeter (retiring by rotation), and declaration of dividend. Special business includes ratification of Cost Auditor's remuneration at Rs. 3 lakh for FY 2025-26, appointment of SAV & Associates LLP as Secretarial Auditor for five years (FY26 to FY30), approval to pay up to 1% of net profits as commission to Non-Executive Directors for five years, and appointment of Ms. Neha Thakore as Independent Woman Director for five years from 1st August 2025. From the MD's message, FY25 revenue grew 6.22% YoY to Rs. 405.51 crore, with EBITDA at Rs. 49.05 crore and PAT at Rs. 29.83 crore. Formulations grew over 20% YoY in Q3, hospital business over 13% YoY, and trade business over 45% YoY in Q2, while the API segment faced pricing pressure from China.
Shareholders can expect dividend payment within 30 days of the AGM if approved; e-voting window runs from 9th to 11th September 2025 with record date of 5th September 2025. The new auditor and director appointments are routine governance items with no material impact expected on the stock price.